Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia

Svetlana A. Ivanova, Diana Z. Osmanova, Maxim B. Freidin, Olga Yu Fedorenko, Anastasia S. Boiko, Ivan V. Pozhidaev, Arkadiy V. Semke, Nikolay A. Bokhan, Alexey A. Agarkov, Bob Wilffert, Anton J. M. Loonen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives: Hyperprolactinaemia (HPRL) is a classical side effect of antipsychotic drugs primarily attributed to blockade of dopamine D2 subtype receptors in the pituitary gland. Although dopamine is considered the primary factor inhibiting prolactin release, the activity of prolactin-producing lactotrophs is also regulated by the secretagogues thyrotrophin releasing hormone, vasoactive intestinal polypeptide and serotonin (5-hydroxytryptamine; 5-HT). Methods: We describe the association between HPRL and a set of 29 SNPs from 5-HT receptor genes HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR3B and HTR6 in a population of 446 Caucasians (221 males/225 females) with a clinical diagnosis of schizophrenia (according to ICD-10: F20) who were treated with classical and/or atypical antipsychotic drugs. Results: None of the studied autosomal markers were found to be associated with HPRL. However, a significant association was established between various HTR2C polymorphisms and HPRL. Conclusions: This study revealed an association between HPRL and X-chromosome haplotypes comprised of the rs569959 and rs17326429 polymorphisms.

Original languageEnglish
Pages (from-to)239-246
Number of pages8
JournalWorld Journal of Biological Psychiatry
Volume18
Issue number3
DOIs
Publication statusPublished - 3 Apr 2017

Fingerprint

Hyperprolactinemia
Serotonin Receptors
Antipsychotic Agents
Schizophrenia
Serotonin
Genes
Prolactin Release-Inhibiting Factors
Lactotrophs
Dopamine D2 Receptors
Vasoactive Intestinal Peptide
X Chromosome
International Classification of Diseases
Pituitary Gland
Thyrotropin
Drug-Related Side Effects and Adverse Reactions
Prolactin
Haplotypes
Single Nucleotide Polymorphism
Dopamine
Hormones

Keywords

  • antipsychotics
  • hyperprolactinaemia
  • polymorphism
  • schizophrenia
  • Serotonin receptors

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia. / Ivanova, Svetlana A.; Osmanova, Diana Z.; Freidin, Maxim B.; Fedorenko, Olga Yu; Boiko, Anastasia S.; Pozhidaev, Ivan V.; Semke, Arkadiy V.; Bokhan, Nikolay A.; Agarkov, Alexey A.; Wilffert, Bob; Loonen, Anton J. M.

In: World Journal of Biological Psychiatry, Vol. 18, No. 3, 03.04.2017, p. 239-246.

Research output: Contribution to journalArticle

Ivanova, SA, Osmanova, DZ, Freidin, MB, Fedorenko, OY, Boiko, AS, Pozhidaev, IV, Semke, AV, Bokhan, NA, Agarkov, AA, Wilffert, B & Loonen, AJM 2017, 'Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia', World Journal of Biological Psychiatry, vol. 18, no. 3, pp. 239-246. https://doi.org/10.1080/15622975.2016.1224926
Ivanova, Svetlana A. ; Osmanova, Diana Z. ; Freidin, Maxim B. ; Fedorenko, Olga Yu ; Boiko, Anastasia S. ; Pozhidaev, Ivan V. ; Semke, Arkadiy V. ; Bokhan, Nikolay A. ; Agarkov, Alexey A. ; Wilffert, Bob ; Loonen, Anton J. M. / Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia. In: World Journal of Biological Psychiatry. 2017 ; Vol. 18, No. 3. pp. 239-246.
@article{8dc70350dc554d01acb3693a1a52b33c,
title = "Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia",
abstract = "Objectives: Hyperprolactinaemia (HPRL) is a classical side effect of antipsychotic drugs primarily attributed to blockade of dopamine D2 subtype receptors in the pituitary gland. Although dopamine is considered the primary factor inhibiting prolactin release, the activity of prolactin-producing lactotrophs is also regulated by the secretagogues thyrotrophin releasing hormone, vasoactive intestinal polypeptide and serotonin (5-hydroxytryptamine; 5-HT). Methods: We describe the association between HPRL and a set of 29 SNPs from 5-HT receptor genes HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR3B and HTR6 in a population of 446 Caucasians (221 males/225 females) with a clinical diagnosis of schizophrenia (according to ICD-10: F20) who were treated with classical and/or atypical antipsychotic drugs. Results: None of the studied autosomal markers were found to be associated with HPRL. However, a significant association was established between various HTR2C polymorphisms and HPRL. Conclusions: This study revealed an association between HPRL and X-chromosome haplotypes comprised of the rs569959 and rs17326429 polymorphisms.",
keywords = "antipsychotics, hyperprolactinaemia, polymorphism, schizophrenia, Serotonin receptors",
author = "Ivanova, {Svetlana A.} and Osmanova, {Diana Z.} and Freidin, {Maxim B.} and Fedorenko, {Olga Yu} and Boiko, {Anastasia S.} and Pozhidaev, {Ivan V.} and Semke, {Arkadiy V.} and Bokhan, {Nikolay A.} and Agarkov, {Alexey A.} and Bob Wilffert and Loonen, {Anton J. M.}",
year = "2017",
month = "4",
day = "3",
doi = "10.1080/15622975.2016.1224926",
language = "English",
volume = "18",
pages = "239--246",
journal = "World Journal of Biological Psychiatry",
issn = "1562-2975",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia

AU - Ivanova, Svetlana A.

AU - Osmanova, Diana Z.

AU - Freidin, Maxim B.

AU - Fedorenko, Olga Yu

AU - Boiko, Anastasia S.

AU - Pozhidaev, Ivan V.

AU - Semke, Arkadiy V.

AU - Bokhan, Nikolay A.

AU - Agarkov, Alexey A.

AU - Wilffert, Bob

AU - Loonen, Anton J. M.

PY - 2017/4/3

Y1 - 2017/4/3

N2 - Objectives: Hyperprolactinaemia (HPRL) is a classical side effect of antipsychotic drugs primarily attributed to blockade of dopamine D2 subtype receptors in the pituitary gland. Although dopamine is considered the primary factor inhibiting prolactin release, the activity of prolactin-producing lactotrophs is also regulated by the secretagogues thyrotrophin releasing hormone, vasoactive intestinal polypeptide and serotonin (5-hydroxytryptamine; 5-HT). Methods: We describe the association between HPRL and a set of 29 SNPs from 5-HT receptor genes HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR3B and HTR6 in a population of 446 Caucasians (221 males/225 females) with a clinical diagnosis of schizophrenia (according to ICD-10: F20) who were treated with classical and/or atypical antipsychotic drugs. Results: None of the studied autosomal markers were found to be associated with HPRL. However, a significant association was established between various HTR2C polymorphisms and HPRL. Conclusions: This study revealed an association between HPRL and X-chromosome haplotypes comprised of the rs569959 and rs17326429 polymorphisms.

AB - Objectives: Hyperprolactinaemia (HPRL) is a classical side effect of antipsychotic drugs primarily attributed to blockade of dopamine D2 subtype receptors in the pituitary gland. Although dopamine is considered the primary factor inhibiting prolactin release, the activity of prolactin-producing lactotrophs is also regulated by the secretagogues thyrotrophin releasing hormone, vasoactive intestinal polypeptide and serotonin (5-hydroxytryptamine; 5-HT). Methods: We describe the association between HPRL and a set of 29 SNPs from 5-HT receptor genes HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR3B and HTR6 in a population of 446 Caucasians (221 males/225 females) with a clinical diagnosis of schizophrenia (according to ICD-10: F20) who were treated with classical and/or atypical antipsychotic drugs. Results: None of the studied autosomal markers were found to be associated with HPRL. However, a significant association was established between various HTR2C polymorphisms and HPRL. Conclusions: This study revealed an association between HPRL and X-chromosome haplotypes comprised of the rs569959 and rs17326429 polymorphisms.

KW - antipsychotics

KW - hyperprolactinaemia

KW - polymorphism

KW - schizophrenia

KW - Serotonin receptors

UR - http://www.scopus.com/inward/record.url?scp=84988666943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988666943&partnerID=8YFLogxK

U2 - 10.1080/15622975.2016.1224926

DO - 10.1080/15622975.2016.1224926

M3 - Article

VL - 18

SP - 239

EP - 246

JO - World Journal of Biological Psychiatry

JF - World Journal of Biological Psychiatry

SN - 1562-2975

IS - 3

ER -